Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ)

CNY 8.92

(0.11%)

Operating Expenses Summary of Shanghai Labway Clinical Laboratory Co., Ltd.

Shanghai Labway Clinical Laboratory Co., Ltd.'s latest annual operating expenses in 2023 was 479.96 Million CNY , down -49.98% from previous year.
Shanghai Labway Clinical Laboratory Co., Ltd.'s latest quarterly operating expenses in 2024 Q3 was 151.92 Million CNY , up 67.99% from previous quarter.
Shanghai Labway Clinical Laboratory Co., Ltd. reported a annual operating expenses of 644.59 Million CNY in annual operating expenses 2022, up 84.51% from previous year.
Shanghai Labway Clinical Laboratory Co., Ltd. reported a annual operating expenses of 349.35 Million CNY in annual operating expenses 2021, up 64.24% from previous year.
Shanghai Labway Clinical Laboratory Co., Ltd. reported a quarterly operating expenses of 151.92 Million CNY for 2024 Q3, up 67.99% from previous quarter.
Shanghai Labway Clinical Laboratory Co., Ltd. reported a quarterly operating expenses of 68.31 Million CNY for 2024 Q1, down -33.76% from previous quarter.

Annual Operating Expenses Chart of Shanghai Labway Clinical Laboratory Co., Ltd. (2023 - 2013)

Historical Annual Operating Expenses of Shanghai Labway Clinical Laboratory Co., Ltd. (2023 - 2013)

Year	Operating Expenses	Operating Expenses Growth
2023	479.96 Million CNY	-49.98%
2022	644.59 Million CNY	84.51%
2021	349.35 Million CNY	64.24%
2020	212.7 Million CNY	0.7%
2019	211.23 Million CNY	0.94%
2018	209.26 Million CNY	-20.38%
2017	262.84 Million CNY	43.94%
2016	182.61 Million CNY	76.38%
2015	103.53 Million CNY	52.83%
2014	67.74 Million CNY	15.21%
2013	58.8 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	88.4 Million CNY	29.4%
2024 Q3	151.92 Million CNY	67.99%
2024 Q1	68.31 Million CNY	-33.76%
2023 Q2	77.28 Million CNY	30.38%
2023 Q3	82.7 Million CNY	7.01%
2023 FY	322.39 Million CNY	-49.98%
2023 Q4	103.13 Million CNY	24.7%
2023 Q1	59.27 Million CNY	-72.53%
2022 Q2	196.72 Million CNY	72.15%
2022 Q1	114.27 Million CNY	-10.66%
2022 FY	644.59 Million CNY	84.51%
2022 Q4	215.8 Million CNY	83.2%
2022 Q3	117.79 Million CNY	-40.12%
2021 Q3	82.67 Million CNY	124.04%
2021 Q4	127.9 Million CNY	54.72%
2021 Q1	-278.72 Million CNY	19.06%
2021 Q2	-343.94 Million CNY	-23.4%
2021 FY	349.35 Million CNY	64.24%
2020 Q4	-344.35 Million CNY	45.3%
2020 FY	212.7 Million CNY	0.7%
2020 Q3	-629.47 Million CNY	-1102.27%
2020 Q2	62.8 Million CNY	142.24%
2020 Q1	-148.7 Million CNY	50.75%
2019 FY	211.23 Million CNY	0.94%
2019 Q4	-301.93 Million CNY	0.0%
2018 FY	209.26 Million CNY	-20.38%
2017 Q1	48.25 Million CNY	-12.45%
2017 Q2	48.25 Million CNY	0.0%
2017 FY	262.84 Million CNY	43.94%
2016 Q3	55.11 Million CNY	52.27%
2016 Q4	55.11 Million CNY	0.0%
2016 FY	182.61 Million CNY	76.38%
2016 Q1	36.19 Million CNY	20.76%
2016 Q2	36.19 Million CNY	0.0%
2015 FY	103.53 Million CNY	52.83%
2015 Q1	21.79 Million CNY	0.0%
2015 Q3	29.97 Million CNY	37.51%
2015 Q4	29.97 Million CNY	0.0%
2015 Q2	21.79 Million CNY	0.0%
2014 FY	67.74 Million CNY	15.21%
2013 FY	58.8 Million CNY	0.0%

Peer Operating Expenses Comparison of Shanghai Labway Clinical Laboratory Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Dian Diagnostics Group Co.,Ltd.	3.35 Billion CNY	85.684%
Hangzhou Tigermed Consulting Co., Ltd.	358.41 Million CNY	-33.914%
Dirui Industrial Co.,Ltd.	387.16 Million CNY	-23.97%
Beijing Strong Biotechnologies, Inc.	702.74 Million CNY	31.701%
Medicalsystem Biotechnology Co., Ltd.	562.06 Million CNY	14.606%
Maccura Biotechnology Co.Ltd	1.18 Billion CNY	59.339%
Guangzhou Wondfo Biotech Co.,Ltd	1.17 Billion CNY	59.165%
Guangdong Hybribio Biotech Co.,Ltd.	631.43 Million CNY	23.988%
BGI Genomics Co., Ltd.	1.93 Billion CNY	75.25%
Amoy Diagnostics Co., Ltd.	574.96 Million CNY	16.522%